Inhibikase Therapeutics, Inc. (IKT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Inhibikase Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.18x | -8.19x | -0.36x | -0.70x | -1.81x | -24.35x |
| P/B Ratio | 1.17x | 2.38x | 0.62x | 0.60x | 0.70x | 7.09x |
| P/S Ratio | 0.00x | 0.00x | 26.00x | 102.12x | 8.63x | 99.29x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | -5127.8% | 94.6% | -266.4% | -28.0% |
| Operating Margin | 0.0% | 0.0% | -7712.0% | -14686.2% | -476.2% | -403.5% |
| Net Margin | 0.0% | 0.0% | -7304.8% | -14625.9% | -476.9% | -407.7% |
| EBITDA Margin | 0.0% | 0.0% | -7643.9% | -14620.4% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 21.70x | 26.37x | 4.13x | 6.59x | 10.47x | 3.13x |
| Quick Ratio | 21.70x | 26.37x | 4.13x | 6.59x | 10.47x | 3.13x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.06x | 0.02x | 0.01x | 0.03x |
YoY = year-over-year change. Source: FMP..